The contract manufacturing market for Pharmaceuticals in China is estimated to be worth USD 13 billion in 2030, predicts Roots Analysis | #biotech # Market research # market # pharma

Health

The contract manufacturing market for Pharmaceuticals in China is estimated to be worth USD 13 billion in 2030, predicts

Owing to reasons, such as a booming economy and availability of skilled labor, outsourcing to Asian CMOs, primarily in China, is considered an attractive business model to pharmaceutical developers / sponsors, across the world

Growing at an annualized rate of over 16.5%, the cell therapy manufacturing market is estimated to reach close to USD 11 Billion by 2030, claims Roots Analysis | #biotech # Market research # market # pharma

Health

Growing at an annualized rate of over 16.5%, the cell therapy manufacturing market is estimated to reach close to USD 11

The approval of KYMIRAH®, YESCARTA®, Alofisel® and Zyntelgo® has increased the interest of pharma stakeholders in cell therapies; further, owing to the technical challenges in this field, outsourcing manufacturing operations has become a necessity

The “Cell and Advanced Therapies Supply Chain Management Market, 2020-2030” report features an extensive study of the innovative software solutions that are being used to improve / optimize various supply chain-related processes of cell and advanced therapies. | #biotech # Market research # market # pharma

Health

The “Cell and Advanced Therapies Supply Chain Management Market, 2020-2030” report features an extensive study of the in

To order this 510+ page report, please visit this - https://www.rootsanalysis.com/reports/view_document/cell-therapies-supply-chain/260.html